SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Rajhansa Dipak (Last) (First) (Middle) C/O TREACE MEDICAL CONCEPTS, INC. 203 FORT WADE RD., SUITE 150 (Street) PONTE VEDRA FL 32081 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 04/22/2021	3. Issuer Name and Ticker or Trading Symbol TREACE MEDICAL CONCEPTS, INC. [ TMCI ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP, Sales	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	167,188	I	As Co-Trustee of the The Rajhansa Family Trust utd November 6, 2020

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	07/24/2027	Common Stock	367,812	$1.05	D
Stock Option (Right to Buy)	(2)	01/23/2028	Common Stock	35,711	$1.05	D
Stock Option (Right to Buy)	(3)	01/22/2029	Common Stock	46,813	$1.57	D
Stock Option (Right to Buy)	(4)	01/21/2030	Common Stock	34,106	$4.02	D
Stock Option (Right to Buy)	(5)	02/02/2031	Common Stock	22,069	$7.03	D

Explanation of Responses:

1. The stock option is partially vested and will vests with respect to the remaining shares in equal annual installments, so that the options will be fully vested on July 24, 2021.

2. The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on January 23, 2022.

3. The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on January 22, 2023.

4. The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on January 21, 2024.

5. The stock option will vest in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Jaime A Frias, as Attorney-in-fact for Dipak A. Rajhansa	04/22/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.